Scott Pollak is a Cardiology physician affiliated with AdventHealth Orlando. OpenAlex indexes 41 publications with 1,268 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1745 N Mills Ave
Orlando, FL 328031851
Telephone
407-841-7151Registry record last updated 29 Jun 2015.
Clinical trials
- Safety and Effectiveness of STSF Catheter Evaluated for Treating Symptomatic Persistent Atrial Fibrillation (PsAF)
Sponsor: Biosense Webster, Inc.
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20241 payment
- Novo Nordisk IncProgram year20241 payment
- Medical Device Business Services, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.8%Beta blocker18.5%Metoprolol Succinate45%Carvedilol24%Metoprolol Tartrate10%Bisoprolol Fumarate6%Atenolol6%Sotalol3%Nebivolol Hcl2%Acebutolol Hcl1%Bisoprolol-Hydrochlorothiazide1%Pindolol1%Part D<11 patientsAdenosine Receptor Agonist12%Regadenoson100%Part B, office-administered≥157 patients+ 18 more classes in this area
Blood & clotting
22%Factor Xa inhibitor16.5%Eliquis77%Xarelto23%Part D≥156 patientsVitamin K antagonist3.2%Warfarin Sodium78%Jantoven22%Part D≥36 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.3%SGLT2 inhibitor0.9%Jardiance100%Part D≥15 patientsPotassium supplement0.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Persistent Atrial Fibrillation Ablation With Contact Force–Sensing Catheter
JACC. Clinical electrophysiology
2020 - Positive Clinical Benefit on Patient Care, Quality of Life, and Symptoms After Contact Force–Guided Radiofrequency Ablation in Persistent Atrial Fibrillation
Circulation Arrhythmia and Electrophysiology
2020 - Economic impact of atrial fibrillation ablation with radiofrequency contact force catheter versus cryoballoon catheter
Journal of Comparative Effectiveness Research
2018 - Healthcare Utilization and Quality of Life Improvement after Ablation for Paroxysmal AF in Younger and Older Patients
Pacing and Clinical Electrophysiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Tarek Mekhail, MD
AdventHealth Orlando
Bridget Koontz, MD
AdventHealth Orlando
Ayman Koteish, MD
AdventHealth Orlando
Chandra Bomma, MD
AdventHealth Orlando
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”